The Mother of all Cannabis - CBG is here.

What is CBG?

Cannabigerol, or CBG, is a non-psychoactive cannabinoid typically most abundant in low-THC and high-CBD cannabis strains, including hemp. Like THC, CBG reacts with the cannabinoid receptors in the brain. CBG, however, acts as a buffer to the psychoactivity of THC by working to alleviate the paranoia sometimes caused by higher levels of THC.

CBG works to fight inflammation, pain, nausea and works to slow the proliferation of cancer cells. Research has shown it also significantly reduces intraocular eye pressure caused by glaucoma. Strains high in CBG will be beneficial treating conditions such as inflammatory bowel disease, Crohn’s disease, and cancer.

Products containing cannabidiol (CBD) have exploded in popularity over the past few years, as the cannabinoid’s reputed anti-inflammatory and anti-oxidant effects have made it into a key ingredient for skincare brands and wellness

 

 

As the major non-intoxicating component in cannabis, CBD is fairly abundant in common cannabis strains, making the cannabinoid’s isolation and use easily translatable to commercial product making operations.

 

 

But recently another non-intoxicating cannabinoid has been making headlines as a potential therapeutic product. Cannabigerol (CBG) is a less abundant cannabinoid, but it has been observed to reduce inflammation, combat pain, and even slow the proliferation of cancer cells.

 

 

CBG may sound similar to CBD on the surface, but dig a little deeper and key differences can be found.

Unlike CBD, which has a relatively low affinity for cannabinoid receptors and acts mostly through indirect interactions with the endocannabinoid system, CBG is thought to elicit its therapeutic effects directly through interaction with the CB1 and CB2 receptors in the brain.

The psychoactive cannabinoid THC also produces its psychoactive effects though interactions with these receptors; CBG has been observed to work as a buffer to THC’s psychoactivity and can even alleviate the feelings of paranoia that sometimes come with consumption of high levels of THC.

A compound made by cannabis plants has been found to wipe out drug-resistant bacteria, raising hopes of a new weapon in the fight against superbugs.

Anti-bacterial CBG

Scientists screened five cannabis compounds for their antibiotic properties and found that one, cannabigerol (CBG), was particularly potent at killing methicillin-resistant Staphylococcus aureus (MRSA), one of the most common hospital superbugs.

Tests in the lab showed that CBG, which is not psychoactive, killed common MRSA microbes and “persister” cells that are especially resistant to antibiotics and that often drive repeat infections. The compound also cleared up hard-to-shift “biofilms” of MRSA that can form on the skin and on medical implants. 

The study was led by Eric Brown, a microbiologist at McMaster University in Hamilton, Ontario.

Now you can use CBG in your micro-batch formulas, just check out the DIY page!

 

Leave a comment

Please note, comments must be approved before they are published